
|Articles|March 14, 2022
What's new on Contemporary Pediatrics: March 14 to 18
A look at what to expect from Contemporary Pediatrics this week
Advertisement
Two pediatric health care providers assess the mental and academic health of our pediatric population as we mark the start of year 3 in the pandemic.
Acne, molluscum, atopic dermatitis, and other dermatological disorders can be detrimental to quality of life for children and their families. Here's what to consider.
Plus, the “Learn the Signs, Act Early” Program, an effort of the Centers for Disease Control and Prevention and the American Academy of Pediatrics, updates developmental surveillance tools.
Newsletter
Access practical, evidence-based guidance to support better care for our youngest patients. Join our email list for the latest clinical updates.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Contemporary Pediatrics
1
Andrew Hershey, MD, discusses latest phase 3 results of fremanezumab-vfrm for pediatric episodic migraine
2
Arik Marcell, MD, MPH, discusses well visit attendance declines for adolescents and young adults
3
Prenatal acid-suppressive medications not linked to neuropsychiatric disorders
4
Weekly review: pediatric migraine, iotaSOFT Insertion System, and more
5





